Hayes M E, Rai A, Cooper R G, Bayley D, Freemont A J, Mawer E B
Manchester University Bone Disease Research Centre, United Kingdom.
Ann Rheum Dis. 1992 May;51(5):632-7. doi: 10.1136/ard.51.5.632.
Previous work has shown that renal metabolism of 25-dihydroxyvitamin D3 (25(OH)D3) to the active metabolite, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) is stimulated by prostaglandin E2 and inhibited by acetylsalicylate (aspirin). As prostaglandins are primary inflammatory mediators and synovial fluid macrophages are known to synthesise 1,25(OH)2D3 in vitro, the effects of prostaglandin E1, prostaglandin E2, and aspirin on the metabolism of 25(OH)D3 by cells cultured from synovial fluid of patients with inflammatory arthritis were investigated. Most cultures contained non-proliferating macrophages which formed 1,25(OH)2D3; however, two of 13 cultures contained colonies of rapidly proliferating fibroblast-like cells which formed 24,25(OH)2D3 (24,25(OH)2D3). Prostaglandin E1 and prostaglandin E2 (0.01-10 mumol/l) induced marked inhibition of 1,25(OH)2D3 synthesis (up to 94%) in a dose dependent manner after preincubations of 24 hours but not over straightforward six hour incubations. Exposure of macrophages to aspirin (1 mumol/l-1 mmol/l) for 24 hours did not affect 1,25(OH)2D3 synthesis unless the cells had been pretreated with lipopolysaccharides, in which instance 1 mM aspirin increased 1,25(OH)2D3 synthesis. Lipopolysaccharide is a macrophage activating factor which stimulates macrophages to form 1,25(OH)2D3, and it also induces prostaglandin synthesis which would be inhibited by aspirin. Taken together these results suggest that prostaglandin E1 and prostaglandin E2 synthesised by macrophages may act in an autocrine manner to attenuate the ability of macrophage activating factors, such as lipopolysaccharide, to stimulate 1,25(OH)2D3 synthesis. Prostaglandins synthesised by other inflammatory cells may also inhibit 1,25(OH)2D3 synthesis in a paracrine manner. In contrast, prostaglandin E2 and aspirin had limited effects on fibroblast 24,25(OH)2D3 synthesis. This study shows that the effects of prostaglandin E1, prostaglandin E2, and aspirin in macrophages contrast with those previously reported for the renal 25(OH)D3-1alpha-hydroxylase, where prostaglandin E2 stimulated and aspirin inhibited enzyme activity. These results further emphasise that synthesis of 1,25(OH)2D3 in non-renal sites is independently regulated, which is consistent with it having an immunological role at a local level rather than playing a part in systemic calcium homeostasis.
先前的研究表明,25-二羟基维生素D3(25(OH)D3)在肾脏中代谢为活性代谢物1,25-二羟基维生素D3(1,25(OH)2D3)的过程受到前列腺素E2的刺激,并被乙酰水杨酸(阿司匹林)抑制。由于前列腺素是主要的炎症介质,且已知滑膜液巨噬细胞在体外可合成1,25(OH)2D3,因此研究了前列腺素E1、前列腺素E2和阿司匹林对炎性关节炎患者滑膜液培养细胞中25(OH)D3代谢的影响。大多数培养物中含有形成1,25(OH)2D3的非增殖巨噬细胞;然而,13个培养物中有2个含有快速增殖的成纤维细胞样细胞集落,它们形成24,25-二羟基维生素D3(24,25(OH)2D3)。前列腺素E1和前列腺素E2(0.01 - 10 μmol/L)在预孵育24小时后以剂量依赖的方式显著抑制1,25(OH)2D3的合成(高达94%),但在直接孵育6小时的情况下则无此作用。巨噬细胞暴露于阿司匹林(1 μmol/L - 1 mmol/L)24小时对1,25(OH)2D3的合成没有影响,除非细胞预先用脂多糖处理,在这种情况下,1 mM阿司匹林会增加1,25(OH)2D3的合成。脂多糖是一种巨噬细胞激活因子,可刺激巨噬细胞形成1,25(OH)2D3,并且它还诱导前列腺素的合成,而这会被阿司匹林抑制。综合这些结果表明,巨噬细胞合成的前列腺素E1和前列腺素E2可能以自分泌方式发挥作用,以减弱巨噬细胞激活因子(如脂多糖)刺激1,25(OH)2D3合成的能力。其他炎性细胞合成的前列腺素也可能以旁分泌方式抑制1,25(OH)2D3的合成。相比之下,前列腺素E2和阿司匹林对成纤维细胞24,25(OH)2D3合成的影响有限。这项研究表明,前列腺素E1、前列腺素E2和阿司匹林在巨噬细胞中的作用与先前报道的肾脏25(OH)D3 - 1α - 羟化酶的作用相反,在肾脏中前列腺素E2刺激而阿司匹林抑制酶活性。这些结果进一步强调了非肾脏部位1,25(OH)2D3的合成是独立调节的,这与它在局部具有免疫作用而非参与全身钙稳态一致。